MedPath

Prospective voluntary clinical research that supports carbohydrate restriction and aerobic exercise and supports physical condition improvement for untreated patients who are pointed out hyperuricemia by medical checkups.

Not Applicable
Conditions
Hyperuricemia
Registration Number
JPRN-UMIN000037135
Lead Sponsor
Sendai Tokushukai Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
500
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who conflict with any of the following will not be included in this study 1) Patients who have already received drug treatment for hyperuricemia 2) Patients who received treatment for hyperuric acid treatment up to 3 months ago and have been discontinued. 3) Patients who have received medical treatment such as diabetes (including boundary type) 4) Patients with a history of myocardial infarction 5) Patients with a history of coronary revascularization (PCI or CABG) 6) Patients with unstable angina 7) Patients with a history of cerebrovascular disease (except asymptomatic lacunar infarction) 8) Patients who have been hospitalized for heart failure 9) Patients with severe liver disease (AST (GOT) or ALT (GPT)> 100 U) 10) Patients with severe renal disease (BUN 25 mg / dL or more or serum creatinine 2.0 mg / dL or more) 11) Pregnant and nursing women 12) Any patient who the research director has judged inappropriate as a research subject

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Amount of change in UA value at study start and 6 months after
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath